Most men who received testosterone therapy did not receive a workup in accordance with guidelines, and some received the ...

Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, ...

A follow-up of the T4DM trial in men with prediabetes or recent-onset type 2 diabetes show no further glycemic improvement ...

Multiple experts who reviewed the donation say the payment could qualify as a conflict because it has the potential to ...

Millions of people around the world take cholesterol-lowering medicines every day. These drugs are among the most commonly ...

The U.S. Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies ...

Federal health officials said testosterone therapy warning labels could be updated after a review found current evidence did ...

The Trump administration wants to update warning labels on testosterone replacement therapies, saying newer evidence does not ...

Fertility may not be a reason for men to avoid GLP-1 medications. In fact, they could see an improvement.After 24 weeks of treatment with GLP-1s, a class of medications ...

The 2015 warnings were added because concerns about heart risks were raised, plus evidence of benefits were “limited” at the ...

HHS is requesting changes to prescribing information for testosterone therapy products following a review of new clinical ...

FDA is removing warning labels from testosterone replacement therapy, or TRT, as a key advancement of men's health.